The CF33, Vaxinia and Oncarlytics Deal, page-130

I agree he seems to have an extreme talent for finding very promising molecules and academics. But IMHO a poor record with capital, CRs, remuneration, amongst other things we're all bored of hearing about.

Doing potentially the largest biotech deal (assuming a T/O) in ASX history is actually a different thing believe it or not. If you can't comprehend that, I don't know what to say about your due diligence for your investments.

I'm simply pointing out the obvious tbh, even if it isn't oft discussed on these forums full of high performing investors like me and you.

Hopper hurry up and get a deal done please, so I can eat goose eggs again.